Current and future status of adjuvant therapy for breast cancer

This publication has 25 references indexed in Scilit:

• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density
  New England Journal of Medicine, 2002
• Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
  Cancer Treatment Reviews, 1999
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• II.1 Tamoxifen's oestrogen-like effects in a breast cancer chemoprevention trial
  European Journal Of Cancer, 1998
• Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
  New England Journal of Medicine, 1998
• Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen
  Breast Cancer Research and Treatment, 1996
• Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
  Journal of Clinical Investigation, 1996
• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
  New England Journal of Medicine, 1992